Health Tech Revolution with Anne Wojcicki, Founder and CEO of 23andMe

London
Wed, Jun 17, 6:30 PM (BST)

About this event

Anne Wojcicki is the co-founder and CEO of 23andMe, a pioneering direct-to-consumer DNA testing firm based in Silicon Valley. 23andMe provides genetic testing for individuals curious about their ancestry and genetic make-up (they product over 150 personalised genetic reports), and is a platform for researchers looking for study participants. It has one of the world’s largest databases of individual genetic information.

A former Wall Street analyst, Anne brings over 10-year experience in healthcare investing, focusing on biotechnology companies. Disillusioned by the culture of Wall Street and its attitude towards health care, she left the investing world with the hope that she could have a positive impact on research and medicine through 23andMe.

Anne teamed up with cofounders Linda Avey and Paul Cusenza to start DNA testing company 23andMe in 2006. 23andMe got a $300 million investment from GSK, formerly GlaxoSmithKline, in July 2018; they are partnering on drug development.

The company has received around $800 million in funding from several prominent technology and health science companies, strategic angel investors, and venture capital firms: GlaxoSmithKline, Sequoia Capital, Fidelity, Euclidean Capital, Altimeter Capital and the Wallenberg Foundation. Other 23andMe investors include Yuri Milner, Johnson & Johnson, MPM Capital, The Roche Venture Fund, GV (Google Ventures), New Enterprise Associates., Casdin Capital, WuXi Healthcare Ventures, Xfund, and Illumina.

23andMe is also doing its own drug discovery and is valued at over $2 billion.

23andMe’s personal genome test kit was named Invention of the Year by Time magazine in 2008, 

In 2013, The Fast Company named Anne as “The Most Daring CEO”.

Speaker

  • Anne Wojcicki

    Anne Wojcicki

    23andMe

    Co-founder/CEO

    Anne Wojcicki is the co-founder & CEO of 23andMe, a pioneering DNA testing firm based in Silicon Valley. It provides genetic testing for individuals curious about their ancestry and genetic make-up (they product over 150 personalised genetic reports), and is a platform for researchers looking for study participants. It has one of the world’s largest databases of individual genetic information.

  • Moderator

    • Thorold Barker

      Thorold Barker

      The Wall Street Journal

      Editor EMEA

      See Bio

    Brought to you by